M. Posner

475 total citations
8 papers, 352 citations indexed

About

M. Posner is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, M. Posner has authored 8 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Otorhinolaryngology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in M. Posner's work include Head and Neck Cancer Studies (5 papers), Lung Cancer Treatments and Mutations (3 papers) and Salivary Gland Tumors Diagnosis and Treatment (2 papers). M. Posner is often cited by papers focused on Head and Neck Cancer Studies (5 papers), Lung Cancer Treatments and Mutations (3 papers) and Salivary Gland Tumors Diagnosis and Treatment (2 papers). M. Posner collaborates with scholars based in United States, France and Belgium. M. Posner's co-authors include Robert I. Haddad, J.-L. Lefebvre, Jan B. Vermorken, Ricardo Hitt, Ezra E.W. Cohen, Daniel Miller, Michael W. Meshad, Brett A. Miles, Tamar Kotz and Hoda Badr and has published in prestigious journals such as British Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

M. Posner

8 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Posner United States 7 173 162 115 87 54 8 352
Sachin Dhumal India 12 242 1.4× 295 1.8× 193 1.7× 98 1.1× 33 0.6× 48 462
Ali Kazemian Iran 10 137 0.8× 96 0.6× 82 0.7× 129 1.5× 22 0.4× 51 331
Anthony La Delfa Canada 7 97 0.6× 105 0.6× 62 0.5× 39 0.4× 90 1.7× 7 286
Savitri C. Ritoe Netherlands 9 74 0.4× 138 0.9× 109 0.9× 87 1.0× 51 0.9× 9 318
Laureen Ribassin-Majed France 8 145 0.8× 187 1.2× 157 1.4× 90 1.0× 30 0.6× 15 452
Samantha Lang United Kingdom 7 61 0.4× 96 0.6× 67 0.6× 48 0.6× 46 0.9× 9 295
T. K. Padmanabhan India 11 116 0.7× 132 0.8× 119 1.0× 50 0.6× 22 0.4× 22 363
Rachel Jia United States 10 87 0.5× 83 0.5× 150 1.3× 61 0.7× 27 0.5× 16 256
Glenn Copeland United States 11 103 0.6× 78 0.5× 150 1.3× 33 0.4× 26 0.5× 15 385
Sophia Hsu United States 8 115 0.7× 282 1.7× 160 1.4× 154 1.8× 34 0.6× 16 400

Countries citing papers authored by M. Posner

Since Specialization
Citations

This map shows the geographic impact of M. Posner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Posner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Posner more than expected).

Fields of papers citing papers by M. Posner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Posner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Posner. The network helps show where M. Posner may publish in the future.

Co-authorship network of co-authors of M. Posner

This figure shows the co-authorship network connecting the top 25 collaborators of M. Posner. A scholar is included among the top collaborators of M. Posner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Posner. M. Posner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Hanna, George J., et al.. (2022). Detection of Occult Recurrence Using Circulating HPV Tumor DNA Among Patients Treated for HPV-driven Oropharyngeal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 112(5). e4–e4. 6 indexed citations
2.
Haddad, Robert I., M. Posner, Ricardo Hitt, et al.. (2018). Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions. Annals of Oncology. 29(5). 1130–1140. 95 indexed citations
3.
Badr, Hoda, et al.. (2015). Development and usability testing of a web‐based self‐management intervention for oral cancer survivors and their family caregivers. European Journal of Cancer Care. 25(5). 806–821. 48 indexed citations
4.
Anderson, Karen S., Jennifer S. Wong, Gypsyamber DʼSouza, et al.. (2011). Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer. British Journal of Cancer. 104(12). 1896–1905. 49 indexed citations
5.
Blanchard, Pierre, Abderrahmane Bourredjem, Jean Bourhis, et al.. (2011). TAXANE-CISPLATIN-5FU AS INDUCTION CHEMOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF THE MACH-NC GROUP. Radiotherapy and Oncology. 98. S6–S6. 7 indexed citations
6.
Karp, Daniel D., Karen J. Ferrante, Thomas G. Tensfeldt, et al.. (2000). A phase I dose escalation study of epidermal growth factor receptor (EGFR) tyrosine kinase (TK) inhibitor CP-358,774 in patients (pts) with advanced solid tumors. Lung Cancer. 29(1). 65–65. 49 indexed citations
7.
Leonidas, John C., W. E. Berdon, Vincent R. Bonagura, et al.. (1991). Parotid enlargement in children seropositive for human immunodeficiency virus: imaging findings.. American Journal of Roentgenology. 157(3). 553–556. 38 indexed citations
8.
Miller, Daniel, et al.. (1981). Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM).. PubMed. 65(9-10). 787–91. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026